COL8A2 and Fuchs endothelial corneal dystrophy: <i>Col8a2</i><sup>Q455K/Q455K</sup> mice, model mice of early-onset FECD, received twice-daily administration of 0.1% emricasan eye drops from 8 to 28 weeks of age.